Trial · NCT01312766
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Total Number of Oocytes Retrieved | hMG-IBSA | 11.6 | Standard Deviation 6.6 | number of oocytes | |
| Total Number of Oocytes Retrieved | Menopur | 9.7 | Standard Deviation 5.9 | number of oocytes | |
| Mean hMG Dose (Total); | hMG-IBSA | 2171.4 | Standard Deviation 980 | Internationa Units (IU) | |
| Mean hMG Dose (Total); | Menopur | 2303.6 | Standard Deviation 906 | Internationa Units (IU) | |
| Embryo Quality (Percentage of Patients With at Least One Top Quality Embryo) | hMG-IBSA | 63.3 | 1.74 | percentage of participants | |
| Embryo Quality (Percentage of Patients With at Least One Top Quality Embryo) | Menopur | 63.3 | 1.65 | percentage of participants | |
| Positive b-hCG Test | hMG-IBSA | 43.7 | percentage of participants | ||
| Positive b-hCG Test | Menopur | 45.2 | percentage of participants | ||
| Controlled Ovarian Stimulation Duration (Days) | hMG-IBSA | 10.2 | Standard Deviation 1.3 | days | |
| Controlled Ovarian Stimulation Duration (Days) | Menopur | 10.6 | Standard Deviation 1.5 | days | |
| 17-β Estradiol (E2) Serum Concentration on the Monitoring Day Before hCG Injection; | hMG-IBSA | 2613.8 | Standard Deviation 1531.6 | pg/ml | |
| 17-β Estradiol (E2) Serum Concentration on the Monitoring Day Before hCG Injection; | Menopur | 2364.0 | Standard Deviation 1441.6 | pg/ml | |
| Implantation Rate | hMG-IBSA | 29.1 | Standard Deviation 41.0 | percentage of embryos transferred | |
| Implantation Rate | Menopur | 28.2 | Standard Deviation 36.9 | percentage of embryos transferred | |
| Clinical Pregnancy Rate, | hMG-IBSA | 33.3 | percentage of participants | ||
| Clinical Pregnancy Rate, | Menopur | 37.1 | percentage of participants | ||
| Number of Mature (Grade III Metaphase II) Oocytes Retrieved. | hMG-IBSA | 10.3 | Standard Deviation 6.0 | oocytes | |
| Number of Mature (Grade III Metaphase II) Oocytes Retrieved. | Menopur | 8.2 | Standard Deviation 5.1 | oocytes | |
| Ratio Mature/Total Number of Oocytes Retrieved. | hMG-IBSA | 85 | percentage of total oocytes retrieved | ||
| Ratio Mature/Total Number of Oocytes Retrieved. | Menopur | 81 | percentage of total oocytes retrieved |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01312766/results